Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06143943
Other study ID # 20231116
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 22, 2022
Est. completion date February 28, 2023

Study information

Verified date November 2023
Source Zhongnan Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this observational study is to examine the anterior segment anatomical parameters associated with the scleral spur and cornea for risk profiling of primary angle-closure glaucoma (PACG). The main question it aims to answer is: • Are there new anatomical parameters of the anterior segment of the eye that can be used early for risk profiling for PACG? Researchers will compare PACG and narrow angle groups to see if there are some anatomical parameters that can distinguish the two.


Description:

We aimed to examine the anterior segment anatomical parameters associated with the scleral spur and cornea for risk profiling of primary angle-closure glaucoma (PACG). This retrospective study included 84 patients with PACG and 84 patients with narrow angles (NA). We collected parametric measurements obtained using anterior-segment optical coherence tomography and IOLMaster 700. Univariate and multivariate logistic regression models were used to compare the ocular parameters between the NA and PACG groups as well as to identify risk factors for PACG. The predictive performance of each parameter was evaluated using the area under the receiver operating characteristic curve (AUROC) analysis.


Recruitment information / eligibility

Status Completed
Enrollment 168
Est. completion date February 28, 2023
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 30 Years to 92 Years
Eligibility Inclusion Criteria: 1. Primary angle-closure glaucoma (PACG) was defined as an occlusion angle with peripheral anterior synechiae and intraocular pressure (IOP) > 21 mmHg or associated with glaucomatous optic neuropathy. The following conditions were identified as possible glaucomatous optic neuropathies, including a vertical cup-to-disc ratio = 0.6, vertical cup-to-disc ratio asymmetry = 0.2, optic disc haemorrhage, and visible retinal nerve fibre layer defect. 2. Participants with narrow angle (NA) were selected from among patients with cataracts. NA was defined as a trabecular-iris angle (TIA) < 15° on anterior segment optical coherence tomography, with the exclusion of glaucomatous optic neuropathy or visual field loss. Exclusion Criteria: (1) severe systemic disease, (2) secondary angle-closure glaucoma, (3) other ocular diseases, (4) history of intraocular surgery, and (5) unclear examination images.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Zhongnan Hospital of Wuhan University Wuhan Hubei

Sponsors (1)

Lead Sponsor Collaborator
Min Ke

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Trabecular scleral-spur angle The angle between the line of the corneal endothelium 750 µm from the scleral spur to the scleral spur and the bilateral line of the scleral spur 2022-11-22 to 2022-12.31
See also
  Status Clinical Trial Phase
Completed NCT03187821 - Comparison of Superior vs Nasal/Temporal Laser Peripheral Iridotomy in Primary Angle Closure N/A
Active, not recruiting NCT00153699 - Relationship Between Topiramate Use and Ocular Angle Status Phase 4
Completed NCT04683055 - Phaco-Trabeculotomy Vs Phaco-Trabeculectomy N/A
Recruiting NCT02613013 - Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure N/A
Recruiting NCT04602923 - Keratometric Change After XEN, Trabeculectomy and Tube Shunts N/A
Terminated NCT01151904 - Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients Phase 4
Recruiting NCT05251792 - Macular Pigment Optical Density in Primary Angle-closure Disease
Recruiting NCT02955641 - Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy N/A
Active, not recruiting NCT04878458 - Phacotrabeculectomy Versus Phacogoniotomy (PVP) in Advanced Primary Angle-closure Glaucoma N/A
Not yet recruiting NCT05593354 - MicroPulse TLT - UK Study
Completed NCT02376725 - Comparing Phaco/IOL Versus Phaco/IOL + Goniosynechialysis in Subjects With PACG N/A
Active, not recruiting NCT00567788 - Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study N/A
Recruiting NCT03323138 - Study on Ex-PRESS Implantation Combined With Phacoemulsification in Primary Angle-closure Glaucoma N/A
Recruiting NCT04703712 - Lens Extraction Combined With Goniosynechialysis Versus Trabeculectomy N/A
Not yet recruiting NCT02964676 - Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Primary Angle Closure Glaucoma N/A
Recruiting NCT02959242 - Dresden Glaucoma and Treatment Study (DGTS)
Completed NCT01298635 - Comparison of Phacotrabeculectomy and Trabeculectomy in the Treatment of Primary Angle-closure Glaucoma (PACG) N/A
Completed NCT00051181 - A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma Phase 3
Enrolling by invitation NCT04381611 - INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register
Recruiting NCT05332665 - AS-OCT Evaluation of Iridocorneal Angle of Patients of Angle Closure Glaucoma After Phacoemulsification